Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

Hangzhou Biotest Biotech Revenue

Hangzhou Biotest Biotech had revenue of 104.79M CNY in the quarter ending September 30, 2025, a decrease of -13.84%. This brings the company's revenue in the last twelve months to 478.69M, down -7.70% year-over-year. In the year 2024, Hangzhou Biotest Biotech had annual revenue of 559.40M with 26.53% growth.

• Revenue (ttm): 478.69M
• Revenue Growth: -7.70%
• P/S Ratio: 12.31
• Revenue / Employee: 793.85K
• Employees: 622
• Market Cap: 5.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	559.40M	117.29M	26.53%
Dec 31, 2023	442.11M	-1.46B	-76.75%
Dec 31, 2022	1.90B	83.07M	4.57%
Dec 31, 2021	1.82B	952.70M	110.09%
Dec 31, 2020	865.37M	656.53M	314.37%